Trial NCT04625699

View at ClinicalTrials.gov 
Org. Study IDs: AAAT0800

Last trial update was posted on 2023-06-06

MeSH Interventions

Durvalumab Tremelimumab

MeSH Conditions

Carcinoma, Non-Small-Cell Lung Lung Neoplasms

Other Conditions

Nonsmall Cell Lung Cancer

Stopping Reasons

Contract was never finalized.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID